Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Radiomics × Other solid neoplasm × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 3 Sarcoma 1 Other solid neoplasm 1 NET 1 Head & Neck 1 Gynecologic 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1 Breast 1

Conditions

Interventions

Surveys and Questionnaires 7 Fluorodeoxyglucose F18 4 Blood Specimen Collection 4 Magnetic Resonance Imaging 3 Data Collection 3 larotrectinib 2 Watchful Waiting 2 Specimen Handling 2 Psychiatric Rehabilitation 2 Genetic Testing 2 Fluorouracil 2 Blood Component Removal 2 trifluridine tipiracil drug combination 1 tegafur-gimeracil-oteracil 1 etoposide phosphate 1 envafolimab 1 alovudine 1 Wechsler Scales 1 Vascular Endothelial Growth Factor A 1 Tumor Burden 1 Tomography, Optical Coherence 1 Tomography, Emission-Computed 1 The Brief Resilience Scale 1 Tegafur 1 Syndecan-1 1 Spinal Cord Stimulation 1 S 1 (combination) 1 Radiomics 1 Radiofrequency Ablation 1 Quality of Life 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04079283 2020-04-02

RIREP

Tianjin Medical University Cancer Institute and Hospital

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡